VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
DNTHDianthus Therapeutics, Inc.$76.45$3.2B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksDNTHDividend History

DNTH logoDianthus Therapeutics, Inc. (DNTH) Dividend History

Income profile from 2016 to 2025 with payout safety and yield-on-cost trend

Trailing Dividend / Share
$0.00
0 payments in last 12 months
Dividend Yield
N/A
Current annualized yield
Payout Ratio
N/A
Unknown
Dividend Streak
0 years
Consecutive annual increases
5Y Dividend CAGRN/A
Current Yield on CostN/A
Yield on Cost Trendunknown

DNTH Dividend Income Check

Safety

Payout ratio data not available yet.

Consistency

0 straight years of dividend increases.

Income Trend

Yield on cost trend needs more history.

DNTH Dividend Scorecard

Yield & Income

Dividend YieldN/A
Trailing DPS$0.00
FrequencyN/A
Payments / 12M0

Payout Safety

Earnings PayoutN/A
Earnings SafetyUnknown
FCF PayoutN/A
FCF SafetyUnknown
Piotroski F-Score2/9

Growth

Growth Streak0 years
3Y CAGRN/A
5Y CAGRN/A
Yield on Cost (5Y)N/A
YOC Trendunknown

Total Returns

Buyback Yield0.0%
Total Shareholder Yield0.0%
1Y Total Return321.9%
5Y Total Return-58.7%
Estimated $10K growth (return + dividends):
5Y ago$4,12610Y ago$3,29120Y ago$3,291

Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). DNTH's recent 5Y regime has been stronger than its full 10Y period, so 5Y can appear higher than 10Y.

DNTH Dividend History

No dividend payment history available

This company has not paid dividends during the available data period.

Get DNTH's next ex-dividend date and payout in your inbox

Monthly dividend calendar — upcoming ex-dates for stocks you follow.

Free. Unsubscribe any time.

Dividend Analysis

Payout Safety

Dianthus Therapeutics, Inc. has limited earnings payout data (Unknown).

Piotroski F-Score: 2/9 — weak financial health.

Growth Track Record

DNTH does not have a current streak of consecutive dividend increases.

Total Shareholder Returns

Beyond cash dividends, DNTH returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.

Income Trend & Total Return

The 5-year total return is -58.7%.

DRIP Growth

A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $3,291 today.

DNTH Dividend vs Peers

Comparable companies in the same industry

Div Yield
—
—
Safety
Unknown
— payout
Streak
0Y
— 5Y CAGR
Total Shareholder
0.0%
#2 of 2
CompanyMkt CapYieldPayoutFCF PayoutStreak5Y GrowthBuybackTSY1Y ReturnSafety
DNTH logoDNTHDianthus Therapeutic…
$3.2B———0—0.0%0.0%321.9%Unknown
1st
OMAB logoOMABGrupo Aeroportuario …
$4.8B5.4%83.7%60.7%38.2%0.0%5.4%-1.7%Watch

DNTH Annual Dividend History (2016–2025)

10 years of dividend data

GrowthDecline
YearDPSYoYPmtsEPSPayoutCoverageFCF/ShareFCF PayoutBuyback YldTotal Shld YldYOC
2025$0.00—0$-4.20——$-3.42—0.0%0.0%—
2024$0.00—0$-2.55——$-2.35—0.0%0.0%—
2023$0.00—0$-8.45——$-7.17—0.0%0.0%—
2022$0.00—0$-7.60——$-7.79—0.0%0.0%—
2021$0.00—0$-3.82——$-17.70—0.0%0.0%—
2020$0.00—0$-27.30——$-23.47—0.0%0.0%—
2019$0.00—0$-33.18——$-26.01—0.0%0.0%—
2018$0.00—0$-27.62——$-23.80—0.0%0.0%—
2017$0.00—0$-16.05——$-11.07————
2016$0.00—0$-4.27——$-3.02————

What if you invested $1,000 in DNTH back in 2016?

Total return with dividends reinvested · 10+ years of data

Calculate Returns

How much would $100/month in DNTH be worth today?

Dollar cost averaging vs lump sum · see how regular investing compounds over time

Run the Numbers

Is DNTH Undervalued Right Now?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

DNTH vs LLY — which is the better buy?

Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.

Compare Now

DNTH — Frequently Asked Questions

Quick answers to the most common questions about buying DNTH stock.

How much dividend does DNTH pay per share?

Dianthus Therapeutics, Inc. (DNTH) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.

When is DNTH's next ex-dividend date?

DNTH's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. DNTH typically pays dividends quarterly.

Is DNTH's dividend safe?

DNTH's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.

How many years has DNTH increased its dividend?

DNTH has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.

How often does DNTH pay dividends?

Dianthus Therapeutics, Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 9+ years from 2016 to 2025.

How much would $10,000 invested in DNTH grow with dividend reinvestment?

With dividends reinvested (DRIP), $10,000 invested in DNTH five years ago would be worth approximately $4,126 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.

What is DNTH's yield on cost for long-term holders?

DNTH's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.